Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Melancholic Depression
NCT00191685Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of duloxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started May 2004; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00191685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191685.